vs

Side-by-side financial comparison of ANAPTYSBIO, INC (ANAB) and GCM Grosvenor Inc. (GCMG). Click either name above to swap in a different company.

GCM Grosvenor Inc. is the larger business by last-quarter revenue ($177.1M vs $108.2M, roughly 1.6× ANAPTYSBIO, INC). ANAPTYSBIO, INC runs the higher net margin — 45.8% vs 32.8%, a 13.0% gap on every dollar of revenue. On growth, ANAPTYSBIO, INC posted the faster year-over-year revenue change (151.1% vs 7.2%). GCM Grosvenor Inc. produced more free cash flow last quarter ($175.0M vs $98.0M). Over the past eight quarters, ANAPTYSBIO, INC's revenue compounded faster (288.3% CAGR vs 27.5%).

AnaptysBio, Inc. is a clinical-stage biotechnology company focused on developing antibody-based immunotherapies for inflammatory diseases, immuno-oncology indications, and rare disease conditions. It primarily serves the U.S. market, advancing its innovative product candidate pipeline to address unmet medical needs via rigorous research and clinical development.

GCM Grosvenor is an American alternative asset management firm, with approximately $76 billion in assets under management and approximately 530 professionals as of 2023.

ANAB vs GCMG — Head-to-Head

Bigger by revenue
GCMG
GCMG
1.6× larger
GCMG
$177.1M
$108.2M
ANAB
Growing faster (revenue YoY)
ANAB
ANAB
+143.9% gap
ANAB
151.1%
7.2%
GCMG
Higher net margin
ANAB
ANAB
13.0% more per $
ANAB
45.8%
32.8%
GCMG
More free cash flow
GCMG
GCMG
$77.0M more FCF
GCMG
$175.0M
$98.0M
ANAB
Faster 2-yr revenue CAGR
ANAB
ANAB
Annualised
ANAB
288.3%
27.5%
GCMG

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ANAB
ANAB
GCMG
GCMG
Revenue
$108.2M
$177.1M
Net Profit
$49.6M
$58.2M
Gross Margin
Operating Margin
61.8%
30.9%
Net Margin
45.8%
32.8%
Revenue YoY
151.1%
7.2%
Net Profit YoY
327.8%
149.2%
EPS (diluted)
$1.64
$0.23

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ANAB
ANAB
GCMG
GCMG
Q4 25
$108.2M
$177.1M
Q3 25
$76.3M
$135.0M
Q2 25
$22.3M
$119.7M
Q1 25
$27.8M
$125.8M
Q4 24
$43.1M
$165.3M
Q3 24
$30.0M
$122.9M
Q2 24
$11.0M
$117.0M
Q1 24
$7.2M
$108.9M
Net Profit
ANAB
ANAB
GCMG
GCMG
Q4 25
$49.6M
$58.2M
Q3 25
$15.1M
$10.5M
Q2 25
$-38.6M
$15.4M
Q1 25
$-39.3M
$463.0K
Q4 24
$-21.8M
$7.6M
Q3 24
$-32.9M
$4.2M
Q2 24
$-46.7M
$4.8M
Q1 24
$-43.9M
$2.1M
Operating Margin
ANAB
ANAB
GCMG
GCMG
Q4 25
61.8%
30.9%
Q3 25
45.5%
32.7%
Q2 25
-117.5%
16.1%
Q1 25
-99.2%
12.2%
Q4 24
-22.4%
26.4%
Q3 24
-75.8%
20.3%
Q2 24
-367.5%
17.8%
Q1 24
-587.8%
-14.7%
Net Margin
ANAB
ANAB
GCMG
GCMG
Q4 25
45.8%
32.8%
Q3 25
19.8%
7.8%
Q2 25
-173.5%
12.9%
Q1 25
-141.6%
0.4%
Q4 24
-50.5%
4.6%
Q3 24
-109.4%
3.4%
Q2 24
-425.3%
4.1%
Q1 24
-612.0%
2.0%
EPS (diluted)
ANAB
ANAB
GCMG
GCMG
Q4 25
$1.64
$0.23
Q3 25
$0.52
$0.16
Q2 25
$-1.34
$0.05
Q1 25
$-1.28
$-0.02
Q4 24
$-0.63
$0.09
Q3 24
$-1.14
$0.03
Q2 24
$-1.71
$0.04
Q1 24
$-1.64
$-0.13

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ANAB
ANAB
GCMG
GCMG
Cash + ST InvestmentsLiquidity on hand
$238.2M
$242.1M
Total DebtLower is stronger
$428.4M
Stockholders' EquityBook value
$37.2M
$27.0M
Total Assets
$364.4M
$813.8M
Debt / EquityLower = less leverage
15.87×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ANAB
ANAB
GCMG
GCMG
Q4 25
$238.2M
$242.1M
Q3 25
$109.8M
$182.7M
Q2 25
$44.3M
$136.3M
Q1 25
$98.6M
$94.5M
Q4 24
$123.1M
$89.5M
Q3 24
$191.6M
$98.4M
Q2 24
$71.8M
$73.9M
Q1 24
$53.7M
$41.9M
Total Debt
ANAB
ANAB
GCMG
GCMG
Q4 25
$428.4M
Q3 25
$429.3M
Q2 25
$430.2M
Q1 25
$431.1M
Q4 24
$432.0M
Q3 24
$432.9M
Q2 24
$433.8M
Q1 24
$384.0M
Stockholders' Equity
ANAB
ANAB
GCMG
GCMG
Q4 25
$37.2M
$27.0M
Q3 25
$-29.4M
$-7.4M
Q2 25
$-44.7M
$-12.3M
Q1 25
$34.0M
$-28.3M
Q4 24
$70.9M
$-27.6M
Q3 24
$84.4M
$-31.9M
Q2 24
$9.9M
$-28.5M
Q1 24
$47.8M
$-26.4M
Total Assets
ANAB
ANAB
GCMG
GCMG
Q4 25
$364.4M
$813.8M
Q3 25
$353.1M
$685.9M
Q2 25
$335.3M
$636.9M
Q1 25
$422.1M
$579.8M
Q4 24
$483.8M
$612.7M
Q3 24
$493.4M
$575.0M
Q2 24
$427.4M
$543.9M
Q1 24
$405.8M
$497.3M
Debt / Equity
ANAB
ANAB
GCMG
GCMG
Q4 25
15.87×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ANAB
ANAB
GCMG
GCMG
Operating Cash FlowLast quarter
$98.0M
$183.5M
Free Cash FlowOCF − Capex
$98.0M
$175.0M
FCF MarginFCF / Revenue
90.5%
98.8%
Capex IntensityCapex / Revenue
0.0%
4.8%
Cash ConversionOCF / Net Profit
1.98×
3.16×
TTM Free Cash FlowTrailing 4 quarters
$19.6M
$326.2M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ANAB
ANAB
GCMG
GCMG
Q4 25
$98.0M
$183.5M
Q3 25
$-27.4M
$79.8M
Q2 25
$-40.2M
$42.0M
Q1 25
$-10.7M
$33.3M
Q4 24
$-66.7M
$148.8M
Q3 24
$-10.1M
$69.0M
Q2 24
$-21.3M
$17.5M
Q1 24
$-37.3M
$24.2M
Free Cash Flow
ANAB
ANAB
GCMG
GCMG
Q4 25
$98.0M
$175.0M
Q3 25
$-27.4M
$78.3M
Q2 25
$-40.3M
$40.8M
Q1 25
$-10.7M
$32.1M
Q4 24
$-66.9M
$132.0M
Q3 24
$-10.1M
$62.2M
Q2 24
$-21.4M
$12.8M
Q1 24
$-37.3M
$20.0M
FCF Margin
ANAB
ANAB
GCMG
GCMG
Q4 25
90.5%
98.8%
Q3 25
-35.9%
58.0%
Q2 25
-180.9%
34.1%
Q1 25
-38.7%
25.5%
Q4 24
-155.3%
79.9%
Q3 24
-33.7%
50.6%
Q2 24
-194.6%
10.9%
Q1 24
-519.3%
18.4%
Capex Intensity
ANAB
ANAB
GCMG
GCMG
Q4 25
0.0%
4.8%
Q3 25
0.0%
1.1%
Q2 25
0.2%
1.0%
Q1 25
0.1%
0.9%
Q4 24
0.6%
10.1%
Q3 24
0.1%
5.5%
Q2 24
0.3%
4.0%
Q1 24
0.4%
3.9%
Cash Conversion
ANAB
ANAB
GCMG
GCMG
Q4 25
1.98×
3.16×
Q3 25
-1.81×
7.61×
Q2 25
2.72×
Q1 25
71.84×
Q4 24
19.54×
Q3 24
16.60×
Q2 24
3.64×
Q1 24
11.40×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ANAB
ANAB

Segment breakdown not available.

GCMG
GCMG

Asset Management1$108.6M61%
Management Service Incentive Performance Fees$61.7M35%
Management Service Incentive Carried Interest$5.1M3%
Service Other$1.8M1%

Related Comparisons